What is Revelation Biosciences Inc?
operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 2.43M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.